Despite bottlenecks caused by higher than expected dispute resolution claims, the federal No Surprises Act appears to be living up to its name, according to a new survey by AHIP and Blue Cross Blue Shield Association.
This initiative marks the largest municipal effort to erase medical debt in partnership with nonprofit RIP Medical Debt, which buys bundled medical debt portfolios from providers, including hospitals and commercial debt buyers.
The Department of Justice has filed a legal brief urging the high court to overturn a lower court decision that limits access to mifepristone, arguing that the ruling would disrupt the FDA's authority and harm the health-care system.
Tyson Foods, one of the first Fortune 100 companies to work with an upstart pharmacy benefit manager, has switched from CVS Caremark to Rightway, in an effort to lower drug benefits to its 140,000 employees.
The new state-based initiative, which will launch in 8 states in the fall of 2024, will connect adults with mental health conditions or substance use disorders to a support system by prioritizing collaboration with primary care providers.
With abortion expected to be front and center during election year, Secretary Xavier Becerra has sent a letter to health plans and insurers to "continue to encourage plans and issuers to ensure they are complying with the law."
UnitedHealth, the nation's largest health insurer, attributes Medicare Advantage claims for much of the increased costs, as well as high December COVID-19 hospital admissions, driven by a more infectious variant.
Manufacturing problems, including failure to properly maintain facilities and equipment, were discovered at Lilly's New Jersey plant during an FDA inspection, as the drugmaker's weight-loss medication Zepbound is in high demand.